• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

IDRA:US

2.6300 USD 0.0100 0.38%

As of 15:49:53 ET on 07/30/2014.

Snapshot for Idera Pharmaceuticals Inc (IDRA)

Open: 2.6800 Day's Range: 2.5500 - 2.7300 Volume: 733,342
Previous Close: 2.6400 52wk Range: 1.2500 - 6.8740 1-Yr Rtn: +89.29%

Stock Chart for IDRA

No chart data available.
  • IDRA:US 2.6300
  • 1D
  • 1M
  • 1Y
2.6400
Interactive IDRA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDRA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4800
Est. EPS (USD) (12/2014) -0.4350
Est. PEG Ratio -
Market Cap (M USD) 214.35
Shares Outstanding (M) 82.44
30 Day Average Volume 1,665,120
Price/Book (mrq) 8.1812
Price/Sale (ttm) 2,604.5093
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDRA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDRA

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Sudhir D Agrawal "Phil"President/CEOLouis J Arcudi IIISenior VP/CFO/Treasurer/Secy
Louis BrennerSenior VP/Chief Medical OfcrRobert D ArbeitVP:Clinical Development
More Company Profile & Key Executives for IDRA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil